T2 Biosystems, Inc. TTOO Open T2 Biosystems, Inc. in new tab
T2 Biosystems, Inc. Analysis (TTOO)
Is T2 Biosystems, Inc. a good investment? T2 Biosystems, Inc. (TTOO) is currently trading at 0.000400 USD.
In terms of valuation, the stock trades at a P/E ratio of 0.02. This relatively low multiple may signal that T2 Biosystems, Inc. is undervalued compared to historical market norms.
Earnings Schedule: T2 Biosystems, Inc. is expected to release its next earnings report on May 19, 2026. The market consensus estimate for Forward EPS is -1.19.
Investor FAQ
Does T2 Biosystems, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is T2 Biosystems, Inc.?
T2 Biosystems, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be May 19, 2026. The company currently has a trailing EPS of -0.03.
Company Profile
T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.
Dividends
Historical Split Corporate Actions
| Split Date | Split Ratio to 1 |
|---|---|
| Oct. 13, 2022 | 0.020000 |
| Oct. 13, 2023 | 0.010000 |
Explore Premium Features
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion